PMC Links for Books (Select 5248954) - PMC

Result Filters

Links from Books

Items: 3

Select item 97268521.

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

Antonio Piga, Filomena Longo, Maria Rita Gamberini, Ersi Voskaridou, Paolo Ricchi, Vincenzo Caruso, Antonello Pietrangelo, Xiaosha Zhang, Jeevan K. Shetty, Kenneth M. Attie, Immacolata Tartaglione

Ther Adv Hematol. 2022; 13: 20406207221134404. Published online 2022 Dec 5. doi: 10.1177/20406207221134404

PMCID:: PMC9726852

Abstract Article PDF–1.2M

Select item 96717522.

Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study

Uwe Platzbecker, Katharina S. Götze, Philipp Kiewe, Ulrich Germing, Karin Mayer, Markus Radsak, Thomas Wolff, Joerg Chromik, Katja Sockel, Uta Oelschlägel, Detlef Haase, Thomas Illmer, Haifa Kathrin Al-Ali, Gerda Silling, Joseph G. Reynolds, Xiaosha Zhang, Kenneth M. Attie, Jeevan K. Shetty, Aristoteles Giagounidis

J Clin Oncol. 2022 Nov 20; 40(33): 3800–3807. Published online 2022 Aug 23. doi: 10.1200/JCO.21.02476

PMCID:: PMC9671752

Abstract Article PDF–184K

Select item 82888963.

The European Medicines Agency Review of Luspatercept for the Treatment of Adult Patients With Transfusion-dependent Anemia Caused by Low-risk Myelodysplastic Syndromes With Ring Sideroblasts or Beta-thalassemia

Julio Delgado, Caroline Voltz, Milena Stain, Ewa Balkowiec-Iskra, Brigitte Mueller, Johanna Wernsperger, Iwona Malinowska, Christian Gisselbrecht, Harald Enzmann, Francesco Pignatti

Hemasphere. 2021 Aug; 5(8): e616. Published online 2021 Jul 19. doi: 10.1097/HS9.0000000000000616